Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Morton

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 17, 2016
Developing and Evaluating Multimedia Patient Education Tools to Better Prepare Prostate-Cancer Patients for Radiotherapy Treatment (Randomized Study)Krista Dawdy, Katija Bonin, Steve Russell, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Pathological predictors for site of local recurrence after radiotherapy for prostate cancerSupriya Chopra, Ants Toi, Nathan Taback, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 11, 2025
Updated results of MR-assisted focal salvage HDR prostate brachytherapy: a prospective studyGregory Paulin, Gerard Morton, Andrew Loblaw, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2021
Gantry-Based 5-Fraction Elective Nodal Irradiation in Unfavorable-Risk Prostate Cancer: Outcomes From 2 Prospective Studies Comparing SABR Boost With MR Dose-Painted HDR Brachytherapy BoostHima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 5, 2021
Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of lifeHima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
International Journal of Radiation Oncology, Biology, Physics|March 22, 2008
Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity resultsTee S Lim, Patrick C F Cheung, D Andrew Loblaw, et al.
Clinical and Translational Radiation Oncology|September 25, 2024
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trialsRachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
International Journal of Radiation Oncology, Biology, Physics|November 18, 2023
Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT)Rachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 28, 2020
Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, CanadaMark T Corkum, Gerard Morton, Alexander V Louie, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2019
Stereotactic Body Radiation Therapy Boost for Intermediate-Risk Prostate Cancer: A Phase 1 Dose-Escalation StudyYasir Alayed, Andrew Loblaw, William Chu, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 17, 2016
Developing and Evaluating Multimedia Patient Education Tools to Better Prepare Prostate-Cancer Patients for Radiotherapy Treatment (Randomized Study)Krista Dawdy, Katija Bonin, Steve Russell, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Pathological predictors for site of local recurrence after radiotherapy for prostate cancerSupriya Chopra, Ants Toi, Nathan Taback, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 11, 2025
Updated results of MR-assisted focal salvage HDR prostate brachytherapy: a prospective studyGregory Paulin, Gerard Morton, Andrew Loblaw, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2021
Gantry-Based 5-Fraction Elective Nodal Irradiation in Unfavorable-Risk Prostate Cancer: Outcomes From 2 Prospective Studies Comparing SABR Boost With MR Dose-Painted HDR Brachytherapy BoostHima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 5, 2021
Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of lifeHima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
International Journal of Radiation Oncology, Biology, Physics|March 22, 2008
Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity resultsTee S Lim, Patrick C F Cheung, D Andrew Loblaw, et al.
Clinical and Translational Radiation Oncology|September 25, 2024
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trialsRachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
International Journal of Radiation Oncology, Biology, Physics|November 18, 2023
Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT)Rachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 28, 2020
Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, CanadaMark T Corkum, Gerard Morton, Alexander V Louie, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2019
Stereotactic Body Radiation Therapy Boost for Intermediate-Risk Prostate Cancer: A Phase 1 Dose-Escalation StudyYasir Alayed, Andrew Loblaw, William Chu, et al.
Pageof 13